Literature DB >> 11508583

Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis.

S Kuiper1, A M van Gestel, H L Swinkels, T M de Boo, J A da Silva, P L van Riel.   

Abstract

OBJECTIVE: To investigate the influences of the menopausal state, sex, and age on the course and outcome of rheumatoid arthritis (RA).
METHODS: A cohort of patients with early RA (209 female, 123 male) was studied. Sex, age, and menopausal state at baseline, and disease activity, radiographic joint destruction, and physical disability during 6 years of followup were assessed.
RESULTS: The Disease Activity Score (DAS) was significantly higher in female compared to male patients at any time point except at the time of inclusion. This was mainly due to postmenopausal patients. Radiographic joint destruction (RJD) was significantly worse in female patients compared to males at the time of inclusion. Postmenopausal patients had significantly higher RJD than premenopausal patients at the time of inclusion and 3 years thereafter. Older male patients showed worse RJD than younger male patients at all time points measured. Physical disability was significantly worse in female compared to male patients, as well as in postmenopausal compared to premenopausal patients, and older male compared to younger male patients. Stepwise regression analysis revealed that at 3 years higher age and female sex were the best predictors for a worse DAS. Higher age and the interaction term between menopausal state and age best predicted higher RJD. Higher age and the interaction term between menopausal state and age best predicted Health Assessment Questionnaire (HAQ) score.
CONCLUSION: Higher age at presentation of RA leads to a more severe disease course in terms of DAS, RJD, and HAQ. Although female sex has a deteriorating effect on the DAS, the menopausal state is responsible for the major part of the differences in outcome between men and women. Postmenopausal state in early RA influences future disability and damage, especially in older patients.

Entities:  

Mesh:

Year:  2001        PMID: 11508583

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

1.  Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes.

Authors:  Wei Wei; Rebecca L Miller; Julie A Leary
Journal:  Anal Chem       Date:  2013-05-28       Impact factor: 6.986

2.  Ovarian aging is associated with gray matter volume and disability in women with MS.

Authors:  Jennifer S Graves; Roland G Henry; Bruce A C Cree; Geralyn Lambert-Messerlian; Ruth M Greenblatt; Emmanuelle Waubant; Marcelle I Cedars; Alyssa Zhu; Peter Bacchetti; Stephen L Hauser; Jorge R Oksenberg
Journal:  Neurology       Date:  2017-12-22       Impact factor: 9.910

3.  Assessment of hemostatic disturbances in women with established rheumatoid arthritis.

Authors:  Aleksandra Vranic; Iva Pruner; Mirjana Veselinovic; Nida Soutari; Anica Petkovic; Vladimir Jakovljevic; Aleksandra Antovic
Journal:  Clin Rheumatol       Date:  2019-06-17       Impact factor: 2.980

4.  Are MRI-detected erosions specific for RA? A large explorative cross-sectional study.

Authors:  Debbie M Boeters; Wouter P Nieuwenhuis; Hanna W van Steenbergen; Monique Reijnierse; Robert B M Landewé; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2018-02-28       Impact factor: 19.103

5.  Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.

Authors:  J Rönnelid; M C Wick; J Lampa; S Lindblad; B Nordmark; L Klareskog; R F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

6.  Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -- results from the DANBIO registry.

Authors:  Damini Jawaheer; Jørn Olsen; Merete Lund Hetland
Journal:  J Rheumatol       Date:  2011-11-15       Impact factor: 4.666

7.  Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter?

Authors:  Damini Jawaheer; Paul Maranian; Grace Park; Maureen Lahiff; Sogol S Amjadi; Harold E Paulus
Journal:  J Rheumatol       Date:  2010-10-01       Impact factor: 4.666

8.  Risk of cancer among rheumatoid arthritis patients in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2009-01-28       Impact factor: 2.506

Review 9.  Autoimmune diseases and reproductive aging.

Authors:  Riley Bove
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

Review 10.  Sex and Management of Rheumatoid Arthritis.

Authors:  Ennio Giulio Favalli; Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Maria Gabriella Raimondo; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.